THE WALTER GROUP for AMERISOURCEBERGEN
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Repeal of LIFO (last-in, first-out).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFERY WALTER | — |
Health Issues HCR
Medicare Prompt Pay Discount exclusion legislation to ensure more appropriate general payment amount for drugs and biological under Part B. of Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFERY WALTER | — |
Medicare/Medicaid MMM
HR 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Oncology Innovation Project - Center for Medicare and Medicaid Innovation. Sequestration cuts to cancer care. HR 1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFERY WALTER | — |
Pharmacy PHA
HR 800 & S. 806 (Medicare Prompt Pay discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. HR 1416 Caner Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts. HR 1919, HR 3204, S. 957 & S. 959, Pharmaceutical pedigree anti-counterfeiting legislation and provisions affecting pharmaceutical compounding Legislation pertaining to drug manufacturing shortages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFERY WALTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.